Summit Therapeutics Inc
NASDAQ:SMMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
US |
|
K
|
Krystal Integrated Services Ltd
NSE:KRYSTAL
|
IN |
|
Telecom Plus PLC
LSE:TEP
|
UK |
|
Endesa SA
LSE:0N9G
|
ES |
|
Af Gruppen ASA
OTC:AGRUF
|
NO |
|
Mixi Inc
TSE:2121
|
JP |
|
Kronos Worldwide Inc
NYSE:KRO
|
US |
|
C
|
CD Projekt SA
SWB:7CD
|
PL |
Wall St Price Targets
SMMT Price Targets Summary
Summit Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SMMT is 28.54 USD with a low forecast of 7.78 USD and a high forecast of 47.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SMMT's stock price target?
Price Target
28.54
USD
According to Wall Street analysts, the average 1-year price target for
SMMT is 28.54 USD with a low forecast of 7.78 USD and a high forecast of 47.25 USD.